RWA Wealth Partners LLC Has $1.02 Million Stock Position in The Cigna Group (NYSE:CI)

RWA Wealth Partners LLC raised its holdings in The Cigna Group (NYSE:CI) by 83.2% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 3,417 shares of the health services provider’s stock after acquiring an additional 1,552 shares during the period. RWA Wealth Partners LLC’s holdings in The Cigna Group were worth $1,023,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Avestar Capital LLC lifted its position in shares of The Cigna Group by 0.8% in the 3rd quarter. Avestar Capital LLC now owns 4,585 shares of the health services provider’s stock worth $1,312,000 after acquiring an additional 35 shares during the period. Eads & Heald Wealth Management lifted its position in shares of The Cigna Group by 1.7% in the 3rd quarter. Eads & Heald Wealth Management now owns 2,123 shares of the health services provider’s stock worth $607,000 after acquiring an additional 35 shares during the period. Relyea Zuckerberg Hanson LLC lifted its position in shares of The Cigna Group by 3.2% in the 4th quarter. Relyea Zuckerberg Hanson LLC now owns 1,113 shares of the health services provider’s stock worth $333,000 after acquiring an additional 35 shares during the period. Strategic Blueprint LLC lifted its position in shares of The Cigna Group by 4.8% in the 3rd quarter. Strategic Blueprint LLC now owns 784 shares of the health services provider’s stock worth $224,000 after acquiring an additional 36 shares during the period. Finally, E&G Advisors LP lifted its position in shares of The Cigna Group by 1.8% in the 3rd quarter. E&G Advisors LP now owns 2,137 shares of the health services provider’s stock worth $611,000 after acquiring an additional 37 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Trading Down 0.1 %

Shares of CI opened at $352.27 on Thursday. The stock has a fifty day moving average price of $349.31 and a two-hundred day moving average price of $317.09. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.67 and a current ratio of 0.67. The Cigna Group has a 52-week low of $240.50 and a 52-week high of $365.71. The company has a market cap of $102.99 billion, a price-to-earnings ratio of 20.26, a PEG ratio of 1.08 and a beta of 0.56.

The Cigna Group (NYSE:CI) last issued its quarterly earnings data on Friday, February 2nd. The health services provider reported $6.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.54 by $0.25. The Cigna Group had a return on equity of 13.59% and a net margin of 2.64%. The firm had revenue of $51.15 billion during the quarter, compared to the consensus estimate of $48.91 billion. During the same quarter in the previous year, the company posted $4.96 EPS. The business’s revenue for the quarter was up 11.8% compared to the same quarter last year. Analysts predict that The Cigna Group will post 28.36 EPS for the current fiscal year.

The Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 20th. Shareholders of record on Tuesday, June 4th will be given a $1.40 dividend. This represents a $5.60 annualized dividend and a yield of 1.59%. The Cigna Group’s payout ratio is 32.20%.

Insider Buying and Selling at The Cigna Group

In other news, CEO David Cordani sold 38,065 shares of The Cigna Group stock in a transaction on Friday, February 9th. The stock was sold at an average price of $335.22, for a total value of $12,760,149.30. Following the completion of the sale, the chief executive officer now directly owns 329,321 shares of the company’s stock, valued at approximately $110,394,985.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, CEO David Cordani sold 38,065 shares of The Cigna Group stock in a transaction on Friday, February 9th. The stock was sold at an average price of $335.22, for a total value of $12,760,149.30. Following the completion of the sale, the chief executive officer now directly owns 329,321 shares of the company’s stock, valued at approximately $110,394,985.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of The Cigna Group stock in a transaction on Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total value of $1,608,446.16. Following the completion of the sale, the senior vice president now directly owns 2,102 shares of the company’s stock, valued at $694,668.96. The disclosure for this sale can be found here. In the last quarter, insiders sold 114,144 shares of company stock worth $39,296,330. 0.60% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of analysts have commented on CI shares. Cantor Fitzgerald reiterated an “overweight” rating and issued a $384.00 price objective on shares of The Cigna Group in a research report on Wednesday, April 10th. StockNews.com upgraded The Cigna Group from a “buy” rating to a “strong-buy” rating in a research report on Thursday, March 14th. Wells Fargo & Company raised their target price on The Cigna Group from $334.00 to $348.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 6th. Oppenheimer restated an “outperform” rating and set a $360.00 target price on shares of The Cigna Group in a research report on Wednesday, January 17th. Finally, Mizuho raised their target price on The Cigna Group from $360.00 to $370.00 and gave the stock a “buy” rating in a research report on Monday, February 5th. Two analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $362.14.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.